Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Gains from Sales and Divestitures (2019)

Historic Gains from Sales and Divestitures for Larimar Therapeutics (LRMR) over the last 1 years, with Q4 2019 value amounting to $15267.0.

  • Larimar Therapeutics' Gains from Sales and Divestitures changed N/A to $15267.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $15267.0, marking a year-over-year change of. This contributed to the annual value of $15267.0 for FY2019, which is N/A changed from last year.
  • As of Q4 2019, Larimar Therapeutics' Gains from Sales and Divestitures stood at $15267.0.
  • Larimar Therapeutics' 5-year Gains from Sales and Divestitures high stood at $15267.0 for Q4 2019, and its period low was $15267.0 during Q4 2019.